Newcastle, England — In a remarkable medical milestone, eight healthy babies have been born from a pioneering fertility technique that incorporates DNA from three individuals, aimed at eliminating severe genetic disorders. This groundbreaking procedure has become a beacon of hope for families facing the risk of transmitting mitochondrial diseases, conditions that can lead to debilitating health issues in children.
The mothers who participated in this innovative treatment were identified as high-risk due to mutations in their mitochondrial DNA, the energy-producing structures within cells. These mutations can have dire consequences, and the announcement of these births has generated excitement and anticipation among the medical community worldwide, especially following the UK’s legislative changes that permitted such procedures in 2015.
A fertility clinic at Newcastle University spearheaded this technique, receiving its first license in 2017. The clinic’s achievements include delivering a balanced mix of four boys and four girls, among them a set of identical twins, all of whom show no signs of the mitochondrial diseases they were at risk of inheriting. Additionally, another pregnancy from this groundbreaking approach is still in progress.
Professor Doug Turnbull, who has dedicated over twenty years to developing this method, expressed relief and joy at the outcomes. “The positive health of these children is reassuring for both us and the families involved,” he noted. His colleague, Professor Mary Herbert, echoed the sentiment, characterizing the arrival of eight healthy babies as “incredibly rewarding.”
Mitochondrial disorders often manifest in early childhood, affecting crucial organs like the brain and heart. Symptoms can range from developmental delays to severe physical disabilities, with many affected children facing shortened life spans. Approximately one in every 5,000 newborns is impacted by these genetic conditions.
The mitochondrial donation treatment (MDT) used in these successful births aims to prevent the transmission of damaged mitochondria. The process begins by fertilizing the mother’s egg with the father’s sperm. Afterward, the nucleus containing the parental genetic material is transferred into a healthy donor egg that has had its own nucleus removed, resulting in a fertilized egg enriched with healthy mitochondria.
The details of these births are documented in two recent studies published in a medical journal. While all eight children were born healthy, there were minor health concerns post-birth, such as urinary infections and temporary muscle jerks. Fortunately, these issues were effectively managed, and genetic testing indicated that the presence of mutated mitochondria in the babies was insufficient to cause disease.
Bobby McFarland, director of the NHS Highly Specialized Service for Rare Mitochondrial Disorders, confirmed that all eight children are thriving and meeting developmental milestones. Their ages range from less than one year to over two years, highlighting the ongoing success of the treatment.
One mother expressed immense gratitude for the chance to welcome a healthy child after years of uncertainty. “Science gave us hope and ultimately our baby,” she shared. Her story reflects the profound impact that advances in reproductive technology can have on families who previously faced limited options.
Although some women facing mitochondrial disorders can utilize pre-implantation genetic testing (PGT) to select healthier eggs, others have all eggs affected by mutations, making MDT a crucial option. The Newcastle team observed a pregnancy rate of 36% among women who underwent MDT, while 41% of those who chose PGT achieved pregnancy.
The journey to this successful outcome has not been without its challenges. Robin Lovell-Badge from the Francis Crick Institute commented on the lengthy process, calling it “frustrating” for at-risk women, while commending the caution exercised by researchers in their approach to this complex therapy. The hope is that these advancements will continue to evolve, offering families even more options for healthy pregnancies in the future.